Tech Company Financing Transactions
One2Treat Funding Round
One2Treat closed a funding round on 9/4/2025. Backers included private investors.
Transaction Overview
Company Name
Announced On
9/4/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Boulevard Baudouin 1er, 25
Louvain-la-Neuve, 1348
Belgium
Louvain-la-Neuve, 1348
Belgium
Phone
Undisclosed
Website
Email Address
Overview
One2Treat is a fast-growing tech company incorporating the patient voice in all strategic decisions about treatment assessments in Pharma R&D. One2Treat is dedicated to transforming the way biopharmaceutical companies design and evaluate clinical trials, and how the overall medical value of a treatment may be communicated, by integrating multiple meaningful dimensions in the treatment assessment.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sébastien Coppe
Browse more venture capital transactions:
Prev: 9/4/2025: Orchard Robotics venture capital transaction
Next: 9/4/2025: Throxy venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs